Only a tiny fraction of adults in the U.S. are using prescription weight loss drugs, while many more are looking forward to taking them if the meds are proven to be safe and effective, a new survey by the healthcare policy organization Kaiser Family Foundation shows.
The results demonstrate the current public awareness regarding this new class of weight loss drugs that are rapidly gaining popularity and show the market opportunity that drugmakers led by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) have yet to address.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased